Page 1,415«..1020..1,4141,4151,4161,417..1,4201,430..»

Michigan Stem Cell Therapy – Foot HealthCare Associates

Posted: November 2, 2018 at 7:40 am

*Absolutely Ethical NO fetal tissue Amniotic Material only from live birth*

Stem cell grafts can be used for effective long-term treatment of:

Regenerative medicine offers solutions and hope for painful medical conditions that are resistant to traditional treatments and greatly enhance the resolution and healing for painful injuries. Therefore, there is the potential to fully heal the body by stimulating the tissues and joints to heal themselves. Regenerative medicine holds the hope of repairing damaged tissue by stimulating the body to heal from within.

Derived from the placental tissue of healthy donors after live elective Cesarean Delivery, Amniotic Stem Cells are formed from the same blastocyst that form the human fetus and Maternal placenta. Furthermore, Amniotic Stem Cellshave a remarkable ability to form into many different types of cells. They act as an internal repair center, dividing endlessly to replenish other cells. After dividing, the stem cell will do one of two things: Become another stem cell or become another type of needed specialized cell (muscle, skin, blood, brain, etc). Stem cells are the building blocks that allow us to go from a single cell organism into a complex multicellular unit.

Stem cell treatment takes advantage of the bodys ability to repair itself. The amniotic stem cells can jump-start the healing process by creating the cells the damaged tissues need.

Surgeries canbe painful and require an extended rehabilitation time. Conversely, regenerative medicine procedures such as stem cell therapy allow the body to heal itself by providing building blocks to stimulate the bodys natural healing processes.

Request a Call from Us! Register for an Appointment Online

Articles and Reference:

Basic Information

Amniotic Fluid as a rich source of mesenchymal Stromal cells for Transplantation Therapy

Amniotic Fluid Pathways& Functions

Gensano Education Link

http://www.MichiganPodiatry.com

Read more from the original source:
Michigan Stem Cell Therapy - Foot HealthCare Associates

Posted in Michigan Stem Cells | Comments Off on Michigan Stem Cell Therapy – Foot HealthCare Associates

University of Michigan Stem Cell Research | Treatment and …

Posted: November 2, 2018 at 7:40 am

Even as research continues on stem cells in U-Ms laboratories, some patients and research volunteers at the U-M Health System already receive stem cell-related therapies.

Every year, more than 200 children and adults receive transplants of stem cells at U-Ms nationally known Blood and Marrow Transplant program. Most of them have leukemia, lymphoma or other cancers.

Since December 2011, this care has had a new home: a state-of-the-art inpatient and outpatient floor within the building that also houses the new C.S. Mott Childrens Hospital and Von Voigtlander Womens Hospital.

These transplants of stem cells taken from the bone marrow or blood of the patient or a donor can save the life of a child or adult.

To learn more about U-Ms program, visit this page.

To find out how you can donate your own marrow or blood stem cells to help a patient at U-M or one of the nations other stem cell treatment sites, visit the National Marrow Donor Programs Be the Match site.

When an idea is ready to make the jump from the research laboratory to the clinic or hospital, its time to do a clinical trial. These tightly controlled tests allow patients to be our partners in developing new treatments and tests.

Many clinical trials at U-M have studied new options for blood and marrow stem cell transplant patients. Some of these studies have led to important new discoveries about how best to treat patients with leukemia, lymphoma and multiple myeloma worldwide. You can learn more about this research here.

Today, our researchers are starting to explore ways to use another kind of stem cell knowledge in fighting other diseases.

Our years of laboratory research on cancer stem cellsthe small number of cells that drive tumor growth and spread, and that are resistant to current treatmentsare now being translated into clinical trials to see how these cells can be stopped. The first trials are now under way.

Tomorrow, even more trials for other diseases could be available, as our laboratory research into other types of stem cells progresses.

To see a list of U-M stem cell trials that are currently seeking participants, visit http://www.umclinicalstudies.org and enter stem cells into the search box at the top of the page.

To learn more about how we protect the health and safety of people who take part in all types of clinical trials at U-M, visit this page.

Read more:
University of Michigan Stem Cell Research | Treatment and ...

Posted in Michigan Stem Cells | Comments Off on University of Michigan Stem Cell Research | Treatment and …

Cancer Stem Cell Research | University of Michigan Rogel …

Posted: November 2, 2018 at 7:40 am

What are adult stem cells?

Every organ and tissue in the body contains a small number of what scientists call adult stem cells or progenitor cells. These cells have three characteristics in common:

1). Adult stem cells can renew themselves through cell division for long periods of time.

2). Adult stem cells retain the ability to give rise to several (but not all) types of cells in the body.

3). Different types of adult stem cells give rise to different specialized cells. Pancreatic stem cells, for example, are the ancestors of insulin-producing islet cells in the pancreas. Hematopoietic stem cells develop into all the different types of cells in the human blood and immune systems.

Cancer stem cells are a type of adult or progenitor cell found in most types of cancer. These cells generally represent just 1% to 3% of all cells in a tumor, but they are the only cells with the ability to regenerate malignant cells and fuel the growth of the cancer.

No. Embryonic stem cells are primitive cells that form inside an early embryo. These cells also can be generated in a laboratory dish during a process called in-vitro fertilization. Four to five days after a human egg is fertilized by sperm, the dividing mass of cells is called a blastocyst. Scientists can remove the inner cell mass from the blastocyst and grow stem cells in a culture dish in the laboratory. Under the right conditions, these stem cells will retain the ability to divide and make copies of themselves indefinitely. Unlike adult stem cells, embryonic stem cells have the ability to give rise to any of the more than 200 different types of cells in the human body.

Cancer research focuses on stem cells present in malignant tumors. Researchers believe current cancer treatments sometimes fail because they don't destroy the cancer stem cells. Think of cancer as a weed: the stem cells are the root while the remaining majority of the cells are the part of the weed above ground. If you remove only the leaves but not the root, the weed will grow back. The same is true for cancer: if you do not kill the cancer stem cells, the cancer is likely to return.

In some cancer types, we are doing a good job. Most cancers when caught early can be successfully treated. But doctors still struggle to treat advanced cancers and some cancer types, such as pancreatic cancer, still have incredibly dismal survival rates. Other cancers, such as head and neck cancers, are often resistant to current therapies, making less-invasive treatments more difficult. In addition, current chemotherapies cause severe side effects because they target all rapidly dividing cells. Treatments that target only cancer stem cells would cause fewer side effects for patients.

Cancer stem cells were first identified in leukemia. U-M researchers discovered the first cancer stem cells in solid tumors, finding them in breast cancer. Since then, cancer stem cells have been identified in brain, colon, head and neck, pancreas and central nervous system tumors. Work is ongoing to identify stem cells in other tumor types.

Researchers take samples of tumors removed from patients during surgery, always with the patient's informed consent. The cells within the tumor are then sorted based on their expression of certain cell markers on their surface. Sorted cells can be injected into mice, which are then watched for new tumor growth. When only specific sorted cells form new tumors, researchers then test those cells for properties of stem cells.

The next step is to understand how cancer stem cells work and identify drugs that will kill the stem cells without harming normal cells.

The work on cancer stem cells is still in early stages, primarily taking place in the laboratory and early clinical trials. U-M is conducting clinical trials of experimental therapies targeted at cancer stem cells in multiple myeloma, pancreatic cancer and breast cancer. Initial results are positive, but additional trials in a larger number of patients will be necessary. If these new drugs are proven to be safe and effective, they could become the first approved cancer treatments to be developed as a result of cancer stem cell research.

Back to top

Updated 03.2016

Original post:
Cancer Stem Cell Research | University of Michigan Rogel ...

Posted in Michigan Stem Cells | Comments Off on Cancer Stem Cell Research | University of Michigan Rogel …

Regenerative Medicine Institute of Nevada RMinLasVegas …

Posted: November 1, 2018 at 11:50 am

Our Technology

Early stem cell research has generally been connected with the controversial utilization of embryonic stem cells. The new focus is on non-embryonic adult mesenchymal stem cells which are discovered in an individual's own blood, bone marrow, and fat.

Learn More

Treatment Process

You have made an important decision to have an stem cell deployment. Its exciting that these devices are presently accessible for therapeutic utilization. Stem cell therapy with your own stem cells might possibly be the next critical development in medicine

Learn More

Hitting retirement age or being blindsided by a sports injury doesnt mean putting your life on hold. At the Regenerative Medicine Institute of Nevada, we understand how better mobility improves quality of life. That's why we offer treatments that can help you achieve better ways to relieve chronic pain, encourage natural tissue healing and faster recovery times.

We offer stem cell therapy in Las Vegas NV to patients to treat a range of conditions. These treatments include the following:

At the Regenerative Medicine Institute of Nevada, only trained and experienced staff perform these procedures. If you need more help in deciding whether stem cell treatment is right for you, talk to us.

Go here to read the rest:
Regenerative Medicine Institute of Nevada RMinLasVegas ...

Posted in Nevada Stem Cells | Comments Off on Regenerative Medicine Institute of Nevada RMinLasVegas …

Knee Conditions Milwaukee, WI | Wisconsin Stem Cell Therapy

Posted: November 1, 2018 at 11:48 am

Stem Cell Therapy for General Knee Pain

Knee pain can severely limit your ability to live an active, healthy life. Many people live for years with chronic knee pain that can make it difficult to work, exercise, and spend time with loved ones. Symptoms may include difficulty bending or stretching out the leg, difficulty putting weight on the knee, trouble walking and running, and feeling pain with other normal movements. The knee may lock up or give out. There are many causes for knee pain, including injury, overuse, regular wear and tear, and common joint conditions. When the knee is hurting, its important to rest and avoid causing more stress to the joint. If the knee pain or swelling doesnt go away or goes away temporarily and keeps coming back, then its time to seek professional treatment. Knee pain and swelling that is sudden and intense may require emergency treatment. Knee pain may gradually get worse and then suddenly become a serious problem.

Traditionally, chronic knee pain is treated with cortisone injections that offer only temporary results, overused pain medications that simply mask the symptoms, and risky knee surgeries that may not always be effective and require lengthy recovery times. At Wisconsin Stem Cell Therapy, we treat knee pain with stem cell therapies that heal the knee conditions naturally using the bodys own regenerative abilities without medications or surgery. These stem cell treatments work to repair damaged tissues, ligaments, muscles, tendons, cartilage, and bone fractures. These procedures treat the underlying cause of the joint pain and have little to no risk of the unwanted side effects seen in traditional treatments.

Osteoarthritis of the knee results from years of wear and tear. Cartilage provides a buffer in the joint between the bones to allow smooth, easy movement. Over time, this cartilage begins to break down and become brittle. Without enough cartilage to protect the bones from rubbing together and causing damage, this friction leads to swelling and painful inflammation. Ultimately, stiffness and soreness can limit mobility, and make moving the joint very painful.

Stem Cell Therapy cells are powerful healing agents that, when used in concentrated doses, can quickly reduce inflammation and scar tissue, and enhance the natural healing processes of the body. Regenerative Cell Therapy is a non-invasive, in-office procedure that safely and effectively alleviates osteoarthritis pain.

When the meniscus cartilage ruptures due to traumatic injuries or due to age-related wear and tear, it is referred to as a meniscus tear. A meniscus tear is usually very painful and limiting. The knee will not operate correctly with this type of injury. The meniscus is located at the knee joint. It is a rubbery piece of cartilage that acts as the bodys shock absorber and also acts as a pad to stabilize and protect the knee. Meniscus tears are of three degrees: severe, moderate and minor. A severe meniscus tear is when bits of ruptured meniscus enter the knee joint and affects the function of the knee causing a lot of pain. But for minor and moderate meniscus tears, the pain usually disappears after conventional treatment or a few weeks of rest. Those suffering from a meniscus tear are increasingly becoming aware of the implications of removing the meniscus though surgical operation. They also prefer not to risk the side effects that come with steroid injections. Wisconsin Stem Cell Therapy offers a non-invasive alternative to surgery and steroid injections for this problem. We also treat the underlying issues that cause the pain using either Wisconsin Stem Cell Therapys advanced form of Anmniotic Regenerative Cell Therapy. By using this regenerative approach, the medical collateral ligament can repair itself and regain its function of holding the knee bones in place, thus relieving pressure on other components such as the particular cartilage and meniscus.

Degeneration of the joints can occur in any of the joints in the body, especially those that experience lots of wear and tear. The knees are used in so many daily motions, feeling pain with each movement is debilitating. Joint degeneration generally develops over time, but can suddenly worsen and become more severe and disabling. Cartilage or other soft tissues within the knee joint can begin to dehydrate, deteriorate, or become damaged from some type of injury. These tissues provide a protective cushion between the bones for smooth movement. Once these start to wear down, or degenerate, friction within the joint can lead to inflammation, swelling, bone spurs, and other painful symptoms. Recent developments in Stem Cell Therapy make it possible to treat degenerative joint conditions naturally, without the need for medications, steroids, or surgery. Stem Cell Therapy uses these cells to target the damaged and deteriorating tissues. Concentrated amounts of these cells are injected into the affected area, and immediately reduce inflammation and reverse damage and deterioration of tissue.

The posterior cruciate ligament (PCL) and anterior cruciate ligament (ACL) are both major ligaments providing strength and stability within the knee joint. Ligaments are thick bands of tissue that connect bones. Injuries to these connective tissues are painful, debilitating, and have historically been a challenge to treat and heal. In the past, these kinds of injuries could cause what was considered permanent damage to the knee joints. Traditionally, the most common treatment for torn ligaments in the knee is arthroscopic surgery and reconstruction. Developments in regenerative medicine make effective, natural treatment of PCL and ACL injuries within reach. Procedures like Stem Cell Therapy offer non-surgical treatment options for those suffering from knee injuries and damage to soft tissues in the joints. Using these cells in concentrated amounts to target the injured area, the body is able to reduce inflammation and heal itself naturally.

Also known as runners knee, chondromalacia is inflammation of the underside of the kneecap, and deterioration of the cartilage that supports it. When this cartilage is damaged or wears down, it becomes difficult to bend and straighten out the leg. This condition is common among young athletes, but may also be present in older individuals with arthritis of the knee. Stem Cell Therapy and other regenerative medicine techniques offer natural treatment alternatives to pain medications, steroid injections, and surgery. Using these cells, our specialists are able to target specific areas of inflammation or injury and restore damaged tissues. These are cutting-edge techniques that have provided relief and healing to so many of our patients with knee pain.

Read more from the original source:
Knee Conditions Milwaukee, WI | Wisconsin Stem Cell Therapy

Posted in Wisconsin Stem Cells | Comments Off on Knee Conditions Milwaukee, WI | Wisconsin Stem Cell Therapy

CONDITIONS – Stem Cell Therapy Washington

Posted: November 1, 2018 at 11:48 am

Schedule Free Phone Consultation

We are looking forward to hearing from you. Please feel free to get in touch via the form below, we will get back to you as soon as possible.

Kitsap Stem Cell Therapy Local in Kitsap CountyCall Us: 206-595-3388

*on comparable procedures including the use comparable stem cell sources.

By filling out our Contact form you agree to our Privacy policy.

SCHEDULE FREE CONSULTATION

Are Stem Cells Safe?

{Stemii Press release Jan 2108} In November 2017, theFDApublished several guidance documents describing regulatory oversight and expectations for HCT/P products, including regenerative medicine products. These documents include the regulatory framework for the development and oversight of regenerative medicine products and are intended to improve the understanding of how these products are regulated.

WE ARE PART OF STEMCELL HEALTH CENTERS

10s of Thousands of procedures have been safely performed!

Serving Kitsap, Jefferson, Mason & Clallam counties, including Poulsbo, Bremerton, Silverdale, Bainbridge Island, Kingston,Port Orchard, Hansville, Keyport, Bangor, Port Gamble, Port Ludlow, Port Townsend, Port Angeles, Sequim, Chimacum, Gig Harbor, Belfair, Seattle, Tacoma, Olympia,

Disclaimer

All statements, opinions and advice on this website are for educational information. They are not a substitute for proper medical diagnosis and care. Like all medical treatments and procedures, results may significantly vary and positive results may not always be achieved. Please refer to FDA regulations regarding regenerative medicine. Pleasecontact usso we may evaluate your specific case.

See the original post here:
CONDITIONS - Stem Cell Therapy Washington

Posted in Washington Stem Cells | Comments Off on CONDITIONS – Stem Cell Therapy Washington

Is testosterone therapy safe? Take a breath before you …

Posted: November 1, 2018 at 11:47 am

Understand the potential risks and consider alternatives before boosting your hormones indefinitely.

Millions of American men use a prescription testosterone gel or injection to restore normal levels of the manly hormone. The ongoing pharmaceutical marketing blitz promises that treating "low T" this way can make men feel more alert, energetic, mentally sharp, and sexually functional. However, legitimate safety concerns linger. For example, some older men on testosterone could face higher cardiac risks.

"Because of the marketing, men have been flooded with information about the potential benefit of fixing low testosterone, but not with the potential costs," says Dr. Carl Pallais, an endocrinologist and assistant professor of medicine at Harvard Medical School. "Men should be much more mindful of the possible long-term complications."

MIND Depression Reduced self-confidence Difficulty concentrating Disturbed sleep

BODY Declining muscle and bone mass Increased body fat Fatigue Swollen or tender breasts Flushing or hot flashes

SEXUAL FUNCTION Lower sex drive Fewer spontaneous erections Difficulty sustaining erections

Images: Thinkstock

A loophole in FDA regulations allows pharmaceutical marketers to urge men to talk to their doctors if they have certain "possible signs" of testosterone deficiency. "Virtually everybody asks about this now because the direct-to-consumer marketing is so aggressive," says Dr. Michael O'Leary, a urologist at Harvard-affiliated Brigham and Women's Hospital. "Tons of men who would never have asked me about it before started to do so when they saw ads that say 'Do you feel tired?'"

Just being tired isn't enough to get a testosterone prescription. "General fatigue and malaise is pretty far down my list," Dr. O'Leary says. "But if they have significant symptoms, they'll need to have a lab test. In most men the testosterone level is normal."

If a man's testosterone looks below the normal range, there is a good chance he could end up on hormone supplementsoften indefinitely. "There is a bit of a testosterone trap," Dr. Pallais says. "Men get started on testosterone replacement and they feel better, but then it's hard to come off of it. On treatment, the body stops making testosterone. Men can often feel a big difference when they stop therapy because their body's testosterone production has not yet recovered."

This wouldn't matter so much if we were sure that long-term hormone therapy is safe, but some experts worry that low-T therapy is exposing men to small risks that could add up to harm over time.

A relatively small number of men experience immediate side effects of testosterone supplementation, such as acne, disturbed breathing while sleeping, breast swelling or tenderness, or swelling in the ankles. Doctors also watch out for high red blood cell counts, which could increase the risk of clotting.

Men on long-term testosterone appear to have a higher risk of cardiovascular problems, like heart attacks, strokes, and deaths from heart disease. For example, in 2010, researchers halted the Testosterone in Older Men study when early results showed that men on hormone treatments had noticeably more heart problems. "In older men, theoretical cardiac side effects become a little more immediate," Dr. Pallais says.

Some physicians also have a lingering concern that testosterone therapy could stimulate the growth of prostate cancer cells. As with the hypothetical cardiac risks, the evidence is mixed. But because prostate cancer is so common, doctors tend to be leery of prescribing testosterone to men who may be at risk.

For men with low blood testosterone levels, the benefits of hormone replacement therapy usually outweigh potential risks. However, for most other men it's a shared decision with your doctor. It offers men who feel lousy a chance to feel better, but that quick fix could distract attention from unknown long-term hazards. "I can't tell you for certain that this raises your personal risk of heart problems and prostate cancer, or that it doesn't," Dr. Pallais says.

So, keep risks in mind when considering testosterone therapy. "I frequently discourage it, particularly if the man has borderline levels," Dr. Pallais says.

These steps can help you feel more energetic today without drugs or dietary supplements:

Pace yourself: Spread out activities throughout the day.

Take a walk: It gives you a lift when you feel pooped out.

Snack smart: Have a snack with fiber and some protein between meals.

A large, definitive trial for hormone treatment of men is still to come. Until then, here is how to take a cautious approach to testosterone therapy.

Have you considered other reasons why you may be experiencing fatigue, low sex drive, and other symptoms attributable to low testosterone? For example, do you eat a balanced, nutritious diet? Do you exercise regularly? Do you sleep well? Address these factors before turning to hormone therapy.

If your sex life is not what it used to be, have you ruled out relationship or psychological issues that could be contributing?

If erectile dysfunction has caused you to suspect "low T" as the culprit, consider that cardiovascular disease can also cause erectile dysfunction.

Inaccurate or misinterpreted test results can either falsely diagnose or miss a case of testosterone deficiency. Your testosterone level should be measured between 7 am and 10 am, when it's at its peak. Confirm a low reading with a second test on a different day. It may require multiple measurements and careful interpretation to establish bioavailable testosterone, or the amount of the hormone that is able to have effects on the body. Consider getting a second opinion from an endocrinologist.

After starting therapy, follow-up with your physician periodically to have testosterone checks and other lab tests to make sure the therapy is not causing any problems with your prostate or blood chemistry.

Approach testosterone therapy with caution if you are at high risk for prostate cancer; have severe urinary symptoms from prostate enlargement; or have diagnosed heart disease, a previous heart attack, or multiple risk factors for heart problems.

Ask your doctor to explain the various side effects for the differentformulations of testosterone, such as gels, patches, and injections. Know what to look for if something goes wrong.

Testosterone therapy is not a fountain of youth. There is no proof that it will restore you to the level of physical fitness or sexual function of your youth, make you live longer, prevent heart disease or prostate cancer, or improve your memory or mental sharpness. Do not seek therapy with these expectations in mind.

If erectile function has been a problem, testosterone therapy might not fix it. In fact, it might increase your sex drive but not allow you to act on it. You may also need medication or other therapy for difficulty getting or maintaining erections.

View original post here:
Is testosterone therapy safe? Take a breath before you ...

Posted in Testosterone Replacement Therapy | Comments Off on Is testosterone therapy safe? Take a breath before you …

Nebraska Farmer Back To Work After Knee Stem Cells – Dr Lox

Posted: October 31, 2018 at 4:44 pm

Nebraska Farmer Back To Work After Knee Stem Cells

3 months after having knee stem cells a Nebraska farmer has returned to tending to the daily chores of his farm. Farm life can be rigorous and the knee often takes a lot of the workload. Knee stem cells may be an option when arthritis or osteoarthritis affects the knee. Stem cells may exert many effects, including controlling the immune response and aid in repair or regeneration. Dr. Lox is an expert in stem cell treatments for arthritis and sports injuries. Often patients with advanced degenerative arthritis (osteoarthritis) or known commonly as arthritis may not want a total knee joint replacement. These patients may consider stem cell treatments as a viable option to knee surgery or knee joint replacement. Whether the patient is a farmer in Nebraska or a professional sports athlete all typically want the best quality of life and the highest level of functioning possible.

If youre in pain or had an injury and are looking for an alternative to surgery, contact us immediately at one of our locations. Our Main Medical Center located in Tampa Bay, Florida (727) 462-5582 or at Beverly Hills, California (310) 975-7033.

Read the original here:
Nebraska Farmer Back To Work After Knee Stem Cells - Dr Lox

Posted in Nebraska Stem Cells | Comments Off on Nebraska Farmer Back To Work After Knee Stem Cells – Dr Lox

Frequently Asked Questions – New Mexico Stem Cell Clinic

Posted: October 29, 2018 at 1:41 am

The umbilical cord is processed in the hospital according to the rules and regulations of the American Association of Tissue Banks (AATB). Approximately 4 weeks prior to a scheduled caesarean section, the mothers OB/GYN asks her if she would like to keep and store her unborn childs umbilical cord for future use. If the mother declines, she is asked if she would like to donate the umbilical cord. If she agrees, she undergoes a review of her medical history, social history, and a blood test. If she is deemed an acceptable donor according to prevailing rules of the AATB, then, at the time of her caesarean section, an experienced technician will clamp the umbilical cord, take it to a sterile room, and remove the contents of the umbilical cord and place it into a blood bag. The bag of umbilical cord blood is then delivered to the lab for processing. Once at the lab, a sample of the umbilical cord blood is sent to a 3rd party independent FDA registered lab for testing according to United States Pharmacopoeia rule 71 (U.S.P. 71), which is a test for all known communicable diseases. While that test is taking place, the stem cells are then processed and removed from the red blood cell products. A sample of the finished stem cell product is then sent to a different 3rd party independent FDA registered lab for sterility testing and for the absence of HLA-DR markers. Only after both lab reports come back as clean and the stem cells have passed the regulatory requirements, are the processed umbilical cord stem cells available for distribution.

Continued here:
Frequently Asked Questions - New Mexico Stem Cell Clinic

Posted in New Mexico Stem Cells | Comments Off on Frequently Asked Questions – New Mexico Stem Cell Clinic

Sustainable Table | Genetic Engineering

Posted: October 26, 2018 at 11:45 pm

Genetically engineered (GE) or genetically modified (GM) foods are produced from plants and animals that have had changes made to their DNA, which introduce or modify genetic traits.

Most packaged foods contain genetically modified organisms (GMOs) engineered to be resistant to herbicides and pests; corn, soybeans and canola oil are prime examples. Concerns about GMOs range from their safety to how genetically modified plants pollen effects the environment, to the increasing use of herbicides associated with their use, with decreasing effectiveness. Polls show that consumers want mandatory labels on foods containing GE ingredients.

All living organisms are made up of cells, within which are strings of DNA molecules possessing instructions to make genes, which form a unique blueprint determining how an organism grows, develops, looks and lives. Genes make up about one percent of the DNA sequence; the rest is responsible for regulating when and how quantities of proteins are made.

Genetic engineering (GE) is the direct manipulation of genetic material (or the genome) by artificial means to alter the hereditary traits of a cell or organism. The process can involve the transfer of specific traits, or genes, from one organism to another, including across diverse species. Other types of genetic engineering include removing or switching off certain genes, adding new genes or introducing desired mutations. An organism that is created or modified by genetic engineering is called a genetically modified organism.

Genetic engineering is different from traditional cross-breeding methods, which have been used for millennia. Traditional breeding more closely resembles accelerated evolution: breeders select organisms with a desired trait and then further select and breed whichever of its offspring most exhibits that trait. A breeder seeking a disease-resistant tomato, for example, will grow many tomatoes, but save the seeds of only the most disease-resistant plants. After several generations, offspring will be much more disease resistant than the progenitor. Traditional breeding is done between the same or closely related species and keeps strands of DNA and gene sequences intact which can also mean that negative traits are reproduced alongside positive traits. Through genetic engineering, on the other hand, it is possible to isolate a single gene out of the whole genome and insert it into another organism.

The future of genetic engineering appears to be even more targeted than that: CRISPR technology (which stands for Clustered Regularly Interspaced Short Palindromic Repeat) allows scientists to isolate and essentially cut and paste very specific sections of DNA. This makes the process much more precise and efficient and inexpensive, making it easier for many more scientists to experiment with the technology. As it becomes more common, many scientists also urge caution, as unintended consequences, whether at the cellular, human or ecosystem level, cannot be known in advance.

Genetically engineered crops have been adopted at an exceptionally rapid rate. In 1997, 17 percent of US soybean acres were planted with GE varieties; by 2014, that figure rose to 94 percent. GE cotton usage went from 10 percent in 1997 to 91 percent in 2014. GE corn acreage increased from 25 percent in 2000 to 92 in 2017.

The vast majority of these crops have been engineered to tolerate herbicides, allowing the plants to be sprayed with a particular chemical while the surrounding weeds die. Glyphosate, the active ingredient in Roundup, is the most common. Other crops are engineered to produce their own natural pesticide (primarily to produce Bacillus thuringiensis, or Bt, a naturally-occurring bacterium that is lethal to a number of agricultural pests), to increase drought resistance or improve nutritional content. The AquAdvantage Salmon, the first GE animal approved for human consumption, was engineered for faster growth, so that it reaches market weight more quickly than a natural salmon.

In addition to corn, soybeans and cotton, the other GE crops that are commercially available in the US are potatoes, papaya, squash, canola, alfalfa, apples and sugar beets. Several others are USDA approved but are not currently produced, including tomatoes, (non-sugar) beets, rice, roses, flax, plums and tobacco. The controversial hormone rBGH (recombinant bovine growth hormone), which increases milk production in dairy cows, is genetically engineered as well.

The FLAVR SAVR tomato, engineered to retain real tomato taste after shipping, was the first GE food approved for human consumption by the US Department of Agriculture (USDA), in 1992, but has since been taken off the market. Most recently, the Impossible Burger a meatless burger that uses a genetically engineered yeast to make its signature ingredient known as heme (which accounts for its meat-like flavor) has been popping up on menus and causing controversy because it does not have FDA approval.

In the US, regulatory approvals for GMOs are a complicated patchwork of the Food and Drug Administration for pharmaceutical developments, the Environmental Protection Agency for insecticide uses and the USDA for food crops.

For many farmers, GE crops require much less work and provide a larger yield, which offsets the substantially higher cost of GE seed. One 2014 metastudy found that globally, GE crops have reduced pesticide use by 37 percent, increased crop yields by 22 percent and increased farmer profits by 68 percent. It is important to note that it was insect-resistant Bt crops that had much more advantage than herbicide-tolerant crops (from Roundup Ready seeds).

A 2014 analysis of USDA data had similar findings for insect-resistant crops in the US, but many more mixed results on herbicide resistance. Certainly, when farmers start with GE seeds, yields and profits increase in the first few years. But some studies show that this tapers off. For reasons discussed below, GMO technology is problematic for farmers and consumers alike.

On a larger scale, corporate interest plays an enormous role in the rapid growth of the technology. In 1980, the Supreme Court ruled that scientists could patent a GE bacterium developed to break down oil spills. This ruling stating that life itself could be patented and owned gave companies an incentive to develop GMOs that could be useful and profitable.

Monsanto (now part of Bayer ), the largest manufacturer of GMOs, has a long history as a chemical maker, including as one of several makers of Agent Orange, the highly toxic defoliant used during the Vietnam War. Following the war, the company turned to making agricultural chemicals, including its bestseller glyphosate herbicide, Roundup, and experimenting with genetically modifying seeds to resist the chemical so that pesticides could be liberally applied without fear of killing the crops. It introduced Roundup Ready seed in 1996 and spun off its chemical operations two years later to focus on biotechnology.

In 2017, Monsantos net sales of GE corn, soybean and cotton seeds and traits totaled $9.5 billion. Most troubling, in the last two decades, is that Monsanto has bought many competitor seed companies, giving it control of a wide swath of the seed market and its accompanying genetic diversity. In 2018, Monsanto was bought by Bayer, further consolidating the production and ownership of seed stocks around the world.

The biotech industry claims that this chemical-based agricultural technology and biotechnology is necessary to feed a growing world population, increase crop yields and adapt to a changing climate. Herbicide-resistant crops do not require tilling, which leaves carbon in the ground and is better for soil structure, and proponents claim that they require less pesticide application than non-GE crops. However, this does not tell the whole story. These crops have actually driven up the use of herbicides like glyphosate, thereby increasing weed resistance and leading to the reintroduction of more potent herbicides. These false narratives are perpetuated by biotech and other agribusiness corporations, but also by land grant universities (which receive more funding from agrochemical companies than public dollars ), many agricultural scientists and farm organizations.

However, technology and the industrialized food system are not currently feeding the world, so there is reason for skepticism about this claim. Globally, agriculture produces more than one and a half times the number of calories needed to feed the world population, yet one in nine people goes hungry. The profit motive of Bayer/Monsanto and other agrochemical companies, as well as their long lack of support for small farmers, should subject their claims of working solely for the public good to scrutiny.

When it comes to increasing calorie production for the parts of the world that sorely need to feed a hungry populace, the International Assessment of Agricultural Knowledge, Science and Technology for Development report from the United Nations proposes that organic and sustainable agriculture is the best solution for countries like Africa and India, where the need is greatest.

Much of the debate around genetically modified food crops and animals focuses on potential threats to human health. But, long-term studies of the impact of consuming GM foods have yet to be done. Some independent studies have documented health effects on animals from eating GMO foods, which have become the subject of controversy.

Companies have determined that GE crops are different enough from those derived by conventional crops to get a patent, but not different enough to require adequate safety testing before they get to market. Additional independent studies and testing are needed. Ways in which GE foods can cause health problems are already documented, particularly in terms of allergens: genes from an allergenic plant can transfer the allergen to the new plant, causing it to provoke a reaction in those sensitive to the first plant. It is also possible that new allergens could be created from combinations of genes that did not previously exist. Overall, though, we do not understand all of the potential health concerns, but that uncertainty is enough to warrant more oversight, not less.

Perhaps the most concerning consequence of herbicide-resistant crops is the huge increase in herbicide use and the evolution of herbicide-resistant superweeds. Weeds resistant to glyphosate, which have survived annual use of the herbicide, have become a problem. A 2016 survey across the Midwest found that one third to upwards of three quarters of fields showed resistant weeds. To address the problem, seed and chemical companies have turned to older chemicals such as 2,4D and dicamba, engineering seeds resistant to these more toxic compounds and increasing their use in farmers fields.

Contrary to industry promises that GE crops would require less pesticide application, chemical use has increased steadily, particularly by farmers growing herbicide-resistant crops. Farmers growing Bt pest-resistant crops have been able to decrease their insecticide use, but scientists are concerned that the effect may not last, as pests also evolve resistance.

One of the major ways that GMOs have impacted the environment, therefore, has been in a mass of side effects stemming from increased pesticide use, including compromised water quality, loss of biodiversity and threats to human health.

While biotech seeds are touted as the only way to feed a growing world population, the data on yields are mixed. It should also be noted that GE crops rely on the promise of reduced pest and weed pressure to boost yields; no successful GE technique has yet increased intrinsic yields (such as more kernels per corncob).

A 2008 literature review by the Union of Concerned Scientists found that herbicide-tolerant GE crops produced no yield gain, while Bt crops produced marginal increases. A 2013 New Zealand study found that average US GE corn yields were slightly lower than non-GE corn yields in western Europe in the same period. 2016 studies by both the National Academies of Sciences and the New York Times found no evidence that yield increases could be tied to GM technology.

Meanwhile, traditional plant breeding techniques have increased yields significantly and have even outperformed GE technology in improving drought tolerance and other factors necessary for farming in a warming climate. But investment in GE research means less funding going to these more promising methods.

Farmers adopt GE seeds and their attendant herbicides ostensibly to make farming easier and more profitable. However, GE seeds cost a lot more than conventional seeds (up to $150 more per bag, according to one report) plus the cost of herbicides. An analysis by AgriWize farm business consultant Aaron Bloom found that GM corn costs an average of $81 more per acre per season than conventional. For many farmers, the yield increase at harvest time makes the upfront costs worth it, but for others, the proliferation of superweeds or simply one bad harvest can put them in debt, with few options for how to get off the GE treadmill.

Congress passed the Plant Patenting Act in 1930, as the rise of hybrid seeds made the business of selling seeds (which since time immemorial have been freely reproducible) profitable for the first time. The law applied to certain plants only, but in 1985, it was expanded to include not only all crops but also their cells, genes and DNA. Seed patents, along with laws on intellectual property, seed marketing and more, have exploded in years since.

Humans have been breeding seeds for aeons, making plants more productive, tastier and better adapted to local conditions. In fact, adaptation has been bred into seeds throughout the ages by subsistence farmers; we take ancient farmer breeding ingenuity for granted. Todays seed patents, meanwhile, bestow rights and profits on multinational companies for discovering the newest traits, ignoring the long and unsung contributions of farmers localized agricultural knowledge.

Patents and other legal measures put control of this long heritage of seed development, and therefore our future food security, in the hands of a very few companies. The seed industry is one of the most concentrated in the US economy. Almost 80 percent of corn and more than 90 percent of soybeans grown in the US feature Monsanto/Bayer seed traits, while the top three seed firms control more than half of the total seed market, with Monsanto/Bayer alone controlling one quarter. Up-to-date numbers on seed market control are difficult to come by, however, because huge mergers in the industry, including the 2017 Dow/Dupont and the 2018 Monsanto/Bayer mergers have shifted the landscape.

These companies value their patents and other intellectual property highly. Monsanto/Bayer has filed suit against 147 farmers for violating the terms of their planting agreement and has also at times threatened or intimidated farmers.

Surveys consistently show that upwards of 90 percent of Americans support labeling of GMO foods, but unlike most developed countries including 28 nations in the European Union, Japan, Australia, Brazil, Russia and China the US had for many years no federal requirement for labels. States responded by taking the matter into their own hands. More than 70 labeling bills or ballot initiatives were introduced across 30 states, and labeling laws were passed in Vermont, Connecticut and Maine. In high-profile cases in Washington State and California, bills were defeated due to aggressive lobbying efforts by big food and biotechnology companies to the tune of $63.6 million in 2014.

In 2016, a federal law was passed, mandating labeling of GE ingredients in foods, which strikes down or pre-empts state labeling laws. The federal laws many critics dubbed it the Denying Americans the Right to Know (DARK) Act, because not only does it override state efforts (which in some cases, as in Vermont, are stringent), but because many GMOs would be exempted from being labeled. Further, the federal law states that labeling can be in the form of a digital QR code or toll-free phone number rather than a textual label that clearly marks the product as containing GMOs.

Read more from the original source:
Sustainable Table | Genetic Engineering

Posted in Genetic Engineering | Comments Off on Sustainable Table | Genetic Engineering

Page 1,415«..1020..1,4141,4151,4161,417..1,4201,430..»